The RACECAT Randomized Clinical Trial Natalia Pérez de la Ossa, PhD1,2; Sònia Abilleira, PhD2; Tudor G. Jovin, PhD3; et alÁlvaro García-Tornel, PhD4; Xavier Jimenez, PhD5; Xabier Urra, PhD6; Pere Cardona, MD7; Dolores Cocho, PhD8; Francisco Purroy, PhD9; Joaquin Serena, PhD10; Luis San Román Manzanera, PhD11; Rosa Maria Vivanco-Hidalgo, PhD2; Mercè Salvat-Plana, RN2; Angel Chamorro, PhD6; Miquel Gallofré, PhD2; Carlos A. Molina, PhD4; Erik Cobo, PhD12; Antoni Davalos, PhD1; Marc Ribo, PhD4; for the RACECAT Trial Investigators JAMA. Published online May 5, 2022. doi:10.1001/jama.2022.4404